VIDEO: Cendakimab safe, efficacious in treating moderate-to-severe AD
- Jeremy Visser
- Sep 4, 2024
- 1 min read
According to a recent study, cendakimab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in adult patients.
top of page
it's where dermatology lives
Search
bottom of page
Comments